biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by KayakerBCon Jun 11, 2017 9:02pm

106 Views

Post# 26350770

RE:RE:RE:And this is for the guy that asked why i dont post anymore

Yes, regardless makes a few positive posts that don't fit with digitel's agenda so digitel (aka Sir PumperDumper) posts another distorted, misrepresentation of the facts.

digitel, please forward your resume to the Donnie administration. He's always in need of folks who have a total disregard for the truth and who can blather on and on hoping nobody will smell the growing pile of BS.

Bullboard Posts

Barrick Gold employees detained in Mali amid ongoing dispute